Lennart van Gils

Showing 1-8 of 8 articles

Interventions for valvular disease

Heterogeneity of debris captured by cerebral embolic protection filters during TAVI

Kroon H, von der Thusen J, Ziviello F, van Wiechen M, Ooms J, Kardys I, Schipper M, van Gils L, Daemen J, de Jaegere P, Van Mieghem N

February 19, 2021 | 10.4244/EIJ-D-20-00744

New large-bore closure technology: time to plug in?

van Gils L, Van Mieghem N

February 7, 2019 | 10.4244/EIJV14I15A262

Embolic protection devices in transcatheter aortic valve implantation

van Gils L, Baumbach A, Himbert D, Lansky A, Vahanian A, Van Mieghem N

May 3, 2017 | 10.4244/EIJV11I2A45

Interventions for valvular disease

MANTA, a novel plug-based vascular closure device for large bore arteriotomies: technical report

van Gils L, Daemen J, Walters G, Sorzano T, Grintz T, Nardone S, Lenzen M, de Jaegere P, Roubin G, Van Mieghem N

September 18, 2016 | 10.4244/EIJV12I7A147

Interventions for valvular disease

TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery

van Gils L, Tchétché D, Latib A, Sgroi C, Manoharan G, Möllmann H, Van Mieghem N

September 18, 2016 | 10.4244/EIJV12SYA6

Interventions for valvular disease

Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial

Van Mieghem N, van Gils L, Ahmad H, van Kesteren F, van der Werf H, Brueren G, Storm M, Lenzen M, Daemen J, van den Heuvel A, Tonino P, Baan Jr J, Koudstaal P.J., Schipper M, van der Lugt A, de Jaegere P

July 20, 2016 | 10.4244/EIJV12I4A84

Interventions for valvular disease

Computed tomography optimised fluoroscopy guidance for transcatheter mitral therapies

Van Mieghem N, Rodriguez-Olivares R, Ben C. Ren B, van Gils L, Maugenest A-M, Geleijnse M, Budde R, Vogelaar J, Verstraeten L, de Jaegere P

March 18, 2016 | 10.4244/EIJV11I12A273

Tools and Techniques - Clinical: Embolic protection devices in transcatheter aortic valve implantation

van Gils L, Baumbach A, Himbert D, Lansky A, Vahanian A, Van Mieghem N

June 19, 2015 | 10.4244/EIJV11I2A45

1

Latest news

Trends and predictors of radiation exposure in percutaneous coronary intervention: the PROTECTION VIII study

FREE ARTICLE - Thomas J. Stocker et al

January 24, 2022

Three-year TAVI outcomes for BAV vs TAV

FREE ARTICLE - Dao Zhou et al.

January 20, 2022

EuroCTO Club Consensus on Dual Lumen Microcatheters for CTO Recanalisation; Predicting Radial Crossover in ACS, the MATRIX score; DAPT duration for BRS; and more…

December 17, 2021

Percutaneous management of left ventricular assist device outflow graft obstruction

FREE ARTICLE - Aleksandra Gasecka et al.

January 19, 2022

Lipid-rich plaque density and LDL-C in statin-treated vs statin-naïve patients

FREE ARTICLE - Rebecca Torguson et al.

January 17, 2022

Redo transcatheter mitral valve replacement in mitral annular calcification

FREE ARTICLE - Jennifer Jdaidani et al

January 13, 2022

TAVI vs SAVR in bicuspid aortic valve stenosis

FREE ARTICLE - Monil Majmundar et al.

January 12, 2022

Valvular disease